{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:22Z","timestamp":1790175142159,"version":"4.1.0"},"reference-count":85,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T00:00:00Z","timestamp":1491782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Along with haemophilia A and B, von Willebrand disease (VWD) and rare bleeding disorders (RBDs) cover all inherited bleeding disorders of coagulation. Bleeding tendency, which can range from extremely severe to mild, is the common symptom. VWD, due to a deficiency and\/or abnormality of von Willebrand factor (VWF), represents the most frequent bleeding disorder, mostly inherited as an autosomal dominant trait. The diagnosis may be difficult, based on a bleeding history and different diagnostic assays, which evaluate the pleiotropic functions of VWF. Different treatment options are available for optimal management of bleeding and their prevention, and long-term outcomes are generally good. RBDs are autosomal recessive disorders caused by a deficiency of any other clotting factor, apart from factor XII, and cover roughly 5% of all bleeding disorders. The prevalence of the severe forms can range from 1 case in 500,000 up to 1 in 2\u20133 million, according to the defect. Diagnosis is based on bleeding history, coagulation screening tests and specific factor assays. A crucial problem in RBDs diagnosis is represented by the non-linear relationship between clinical bleeding severity and residual clotting levels; genetic diagnosis may help in understanding the phenotype. Replacement therapies are differently available for patients with RBDs, allowing the successful treatment of the vast majority of bleeding symptoms.<\/jats:p>","DOI":"10.3390\/jcm6040045","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T02:39:17Z","timestamp":1492051157000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders"],"prefix":"10.3390","volume":"6","author":[{"given":"Giancarlo","family":"Castaman","sequence":"first","affiliation":[{"name":"Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Linari","sequence":"additional","affiliation":[{"name":"Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0029-1225757","article-title":"Introduction: Rare bleeding disorders: General aspects of clinical features, diagnosis and management","volume":"35","author":"Peyvandi","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: A multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0031-1280567","article-title":"Von Willebrand disease: Local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_5","first-page":"17","article-title":"Von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: Structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"Von Willebrand factor propeptide: Biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0021-9258(18)32879-5","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain","volume":"258","author":"Wagner","year":"1983","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI112064","article-title":"Biosynthesis of von Willebrand protein by human megakaryocytes","volume":"76","author":"Sporn","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1538-7836.2005.01360.x","article-title":"Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions","volume":"3","author":"Dong","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","first-page":"257","article-title":"Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation","volume":"14","author":"Ruggeri","year":"2001","journal-title":"Clin. Haematol."},{"key":"ref_12","first-page":"94","article-title":"Von Willebrand\u2019s disease in the year 2003: Towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"key":"ref_13","first-page":"EREP02","article-title":"The factor VIII\/von Willebrand factor complex: Basic and clinical issues","volume":"88","author":"Federici","year":"2003","journal-title":"Haematologica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"the European Group on von Willebrand Disease (EUVWD). Principles of care for diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sadler, J.E. (2009). Low von Willebrand factor: Sometimes a risk factor and sometimes a disease. Hematology.","DOI":"10.1182\/asheducation-2009.1.106"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281031","article-title":"The International Society on Thrombosis and Haemostasis von Willebrand Disease Database: An update","volume":"37","author":"Hampshire","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: A two-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"Laffan","year":"2001","journal-title":"Transfus. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Albanez","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: A standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s Disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1 VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2009-01-153296","article-title":"How I treat von Willebrand disease","volume":"114","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: A diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(89)90915-X","article-title":"Desmopressin and thrombosis","volume":"2","author":"Mannucci","year":"1989","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and the phenotype in type 1 von Willebrand disease (VWD): Results from the European study MCMDM-1 VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: A cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3324\/haematol.2013.084145","article-title":"Pathogen safety of long-term treatments for bleeding disorders: Still relevant to current practice","volume":"98","author":"Canaro","year":"2013","journal-title":"Haematologica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MBC.0b013e3283254570","article-title":"Von Willebrand factor\/factor VIII concentrates in the treatment of von Willebrand disease","volume":"20","author":"Batlle","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Federici, A.B., and Lee, C.A. (2011). The use of plasma-derived concentrates. Von Willebrand Disease, Wiley-Blackwell.","DOI":"10.1002\/9781444329926"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","article-title":"Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor","volume":"39","author":"Mannucci","year":"1987","journal-title":"Eur. J. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"Von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"ref_36","first-page":"33","article-title":"Surgical prophylaxis in von Willebrand\u2019s disease: A difficult balance to manage","volume":"6","author":"Franchini","year":"2008","journal-title":"Blood Transfus."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613227","article-title":"Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand\u2019s disease","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/j.1538-7836.2005.01435.x","article-title":"Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low FVIII content treated with three virus-inactivation\/removal methods","volume":"3","author":"Federici","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1008906103637","article-title":"Recombinant von Willebrand factor: Potential therapeutic use","volume":"8","author":"Fischer","year":"1999","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: A prospective trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/01.mbc.0000167659.23262.18","article-title":"Long-term prophylaxis in von Willebrand disease","volume":"16","author":"Berntorp","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0049-3848(09)70153-7","article-title":"The role of prophylaxis in the management of von Willebrand disease: Today and tomorrow","volume":"124","author":"Abshire","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2013060","DOI":"10.4084\/mjhid.2013.060","article-title":"Von Willebrand factor, angiodysplasia and angiogenesis","volume":"5","author":"Randi","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2007.01573.x","article-title":"Highly purified VWF\/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease. The PRO.WILL study","volume":"13","author":"Federici","year":"2007","journal-title":"Haemophilia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand\u2019s disease: Results from the von Willebrand disease prophylaxis network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid\u2014An old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","article-title":"The medical management of abnormal uterine bleeding in reproductive-aged women","volume":"214","author":"Bradley","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: Long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0033-1349221","article-title":"Rare bleeding disorders: Worldwide efforts for classification, diagnosis, and management","volume":"39","author":"Peyvandi","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: Diagnosis, and management","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2016.11.008","article-title":"Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders","volume":"148","author":"Palla","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: Results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MOH.0b013e3283497e3e","article-title":"Novel aspects of FXIII deficiency","volume":"18","author":"Muszbek","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Factor XIII and fibrinogen SSC Subcommittee of the ISTH. Diagnosis and classification of FXIII deficiencies","volume":"9","author":"Kohler","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_58","unstructured":"Zivelin, A., and Seligsohn, U. (2017, February 27). Mutations causing rare bleeding disorders. Available online: http:\/\/www.isth.org\/?MutationsRareBleedin."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/j.1538-7836.2006.02094.x","article-title":"The molecular basis of quantitative fibrinogen disorders","volume":"4","author":"Asselta","year":"2006","journal-title":"J. Thromb. Haemot."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: An update","volume":"39","author":"Casini","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Casini, A., and Brungs, T. (2017). Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: A systematic literature review and report of a novel mutation. J. Thromb. Haemost.","DOI":"10.1111\/jth.13655"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom Haemophilia Centre Doctors\u2019 Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_63","first-page":"575","article-title":"Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy","volume":"12","author":"Rocino","year":"2014","journal-title":"Blood Transfus."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2000.01993.x","article-title":"Prenatal and peripartum management of congenital afibrinogaenemia","volume":"109","author":"Kobayashi","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(88)90567-3","article-title":"The molecular basis of blood coagulation","volume":"53","author":"Furie","year":"1988","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.moh.0000155016.30296.90","article-title":"Coagulation factor V: A plethora of anticoagulant molecules","volume":"12","author":"Kalafatis","year":"2005","journal-title":"Curr. Opin. Hematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2516.2001.00100.x","article-title":"Current therapy for rare factor deficiencies","volume":"7","author":"Nugent","year":"2001","journal-title":"Haemophilia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0033-1349223","article-title":"Combined deficiency of coagulation factors V and VIII: An update","volume":"39","author":"Zheng","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_69","unstructured":"Colman, R.W., and Marder, V.J. (2006). Overview of hemostasis. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Lippincott Williams & Wilkins. [5th ed.]."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1160\/TH04-10-0650","article-title":"Clinical phenotypes and factor VII genotype in congenital FVII deficiency","volume":"93","author":"Mariani","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.2830100112","article-title":"Factor VII deficiency","volume":"10","author":"Ragni","year":"1981","journal-title":"Am. J. Hematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1538-7836.2003.00395.x","article-title":"Thrombosis in inherited factor VII deficiency","volume":"1","author":"Mariani","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3324\/haematol.2012.074039","article-title":"Prophylaxis in congenital factor VII deficiency: Indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)","volume":"98","author":"Napolitano","year":"2013","journal-title":"Haematologica"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0029-1225763","article-title":"Factor X deficiency","volume":"35","author":"Menegatti","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1054\/blre.2002.0191","article-title":"Factor X deficiency","volume":"16","author":"Uprichard","year":"2002","journal-title":"Blood Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.thromres.2006.01.015","article-title":"Prophylaxis in rare coagulation disorders-factor X deficiency","volume":"118","author":"Auerswald","year":"2006","journal-title":"Thromb. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: Initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1538-7836.2009.03395.x","article-title":"Factor XI deficiency in humans","volume":"7","author":"Seligsohn","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2516.2000.00053.x","article-title":"Factor XI deficiency and its management","volume":"6","year":"2000","journal-title":"Haemophilia"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2516.2006.01304.x","article-title":"Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacemet therapy","volume":"12","author":"Salomon","year":"2006","journal-title":"Haemophilia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/hae.12655","article-title":"Factor XI replacement for inherited factor XI deficiency in routine clinical practice: Results of the HEMOLEVEN prospective 3-year postmarketing study","volume":"21","author":"Bauduer","year":"2015","journal-title":"Haemophilia"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0037-1616201","article-title":"Physiopathology and regulation of factor XIII","volume":"86","author":"Ichinose","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0029-1225765","article-title":"Factor XIII deficiency","volume":"35","author":"Karimi","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: A systematic review of literature","volume":"19","author":"Sharief","year":"2013","journal-title":"Haemophilia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/asheducation-2016.1.663","article-title":"Treatment of rare factor deficiencies in 2016","volume":"2016","author":"Peyvandi","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/4\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:32:20Z","timestamp":1760207540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/4\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,10]]},"references-count":85,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"alternative-id":["jcm6040045"],"URL":"https:\/\/doi.org\/10.3390\/jcm6040045","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,10]]}}}